Global Edition
Global Edition
UK Edition
EU Edition
US Edition

Understand the story, not the spin.

Markets

Senate panel hears testimony on COVID‑19 vaccine cancer risk

Published 5 June 2026

A U.S. Senate subcommittee heard testimony on Wednesday from doctors and researchers who presented clinical observations and studies suggesting plausible biological links between COVID-19 mRNA vaccines and increased cancer risks, while other experts and officials maintained there is no clinical evidence proving causation.

The hearing, titled “Plausible Mechanisms of COVID-19 Injections Causing Cancer and Attacks on Scientific Publications,” was convened by Senator Ron Johnson, who chairs the Permanent Subcommittee on Investigations. Multiple medical professionals described patterns they have witnessed in their practices.

Dr. Angus Dalgleish, a professor emeritus of oncology at the University of London, testified that beginning in late 2021 he observed unexpected cancer relapses in patients who had been in stable remission for years, consistently following COVID-19 booster administration. He described seeing a sudden wave of aggressive recurrences in early 2022, with the common factor being a recent booster dose. Dalgleish pointed to potential mechanisms including immune dysregulation, T-cell suppression, and concerns over lipid nanoparticles and residual DNA fragments in some...

Now playing
0:00 / 0:00